Registered entities
Alessa Therapeutics, Inc.
Reg. No. 830762950United States
Social engagement
Social engagement: 1K social following, 2 posts in the last 12 months — below the industry typical range.
Investor mix
6 investors on record; lead investors include Mission BioCapital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Accelerator & incubator | 1 | 17% |
| Other / undisclosed | 2 | 33% |
Recent activity
29 May 2026
Recognition
8 Jan 2026
Recognition
regulatory